718 related articles for article (PubMed ID: 28043870)
1. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis.
Johnston A; Xing X; Wolterink L; Barnes DH; Yin Z; Reingold L; Kahlenberg JM; Harms PW; Gudjonsson JE
J Allergy Clin Immunol; 2017 Jul; 140(1):109-120. PubMed ID: 28043870
[TBL] [Abstract][Full Text] [Related]
2. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis
Shao S; Fang H; Zhang J; Jiang M; Xue K; Ma J; Zhang J; Lei J; Zhang Y; Li B; Yuan X; Dang E; Wang G
FASEB J; 2019 Jun; 33(6):6813-6828. PubMed ID: 30811955
[TBL] [Abstract][Full Text] [Related]
4. Increased neutrophil-derived IL-17A identified in generalized pustular psoriasis.
Lan Y; Wu X; Zhong X; Song P; Liu L; Liu Y; Ai X; Han C; Zhang Z
Exp Dermatol; 2024 Feb; 33(2):e15026. PubMed ID: 38414093
[TBL] [Abstract][Full Text] [Related]
5. Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders.
Liang Y; Xing X; Beamer MA; Swindell WR; Sarkar MK; Roberts LW; Voorhees JJ; Kahlenberg JM; Harms PW; Johnston A; Gudjonsson JE
J Allergy Clin Immunol; 2017 Apr; 139(4):1217-1227. PubMed ID: 27884600
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Generalized Pustular Psoriasis.
Marrakchi S; Puig L
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):13-19. PubMed ID: 35061228
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase Modulates Inflammation in Generalized Pustular Psoriasis and Additional Rare Pustular Skin Diseases.
Haskamp S; Bruns H; Hahn M; Hoffmann M; Gregor A; Löhr S; Hahn J; Schauer C; Ringer M; Flamann C; Frey B; Lesner A; Thiel CT; Ekici AB; von Hörsten S; Aßmann G; Riepe C; Euler M; Schäkel K; Philipp S; Prinz JC; Mößner R; Kersting F; Sticherling M; Sefiani A; Lyahyai J; Sondermann W; Oji V; Schulz P; Wilsmann-Theis D; Sticht H; Schett G; Reis A; Uebe S; Frey S; Hüffmeier U
Am J Hum Genet; 2020 Sep; 107(3):527-538. PubMed ID: 32758447
[TBL] [Abstract][Full Text] [Related]
8. Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ.
Tu J; Yin Z; Guo J; He F; Long F; Yin Z
Int Immunopharmacol; 2020 Feb; 79():106045. PubMed ID: 31863918
[TBL] [Abstract][Full Text] [Related]
9. Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis.
Baum P; Visvanathan S; Garcet S; Roy J; Schmid R; Bossert S; Lang B; Bachelez H; Bissonnette R; Thoma C; Krueger JG
J Allergy Clin Immunol; 2022 Apr; 149(4):1402-1412. PubMed ID: 34678325
[TBL] [Abstract][Full Text] [Related]
10. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
11. Innate immune cells express IL-17A/F in acute generalized exanthematous pustulosis and generalized pustular psoriasis.
Kakeda M; Schlapbach C; Danelon G; Tang MM; Cecchinato V; Yawalkar N; Uguccioni M
Arch Dermatol Res; 2014 Dec; 306(10):933-8. PubMed ID: 25030504
[TBL] [Abstract][Full Text] [Related]
12. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
13. Generalized pustular psoriasis - a model disease for specific targeted immunotherapy, systematic review.
Boehner A; Navarini AA; Eyerich K
Exp Dermatol; 2018 Oct; 27(10):1067-1077. PubMed ID: 29852521
[TBL] [Abstract][Full Text] [Related]
14. IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis.
Catapano M; Vergnano M; Romano M; Mahil SK; Choon SE; Burden AD; Young HS; Carr IM; Lachmann HJ; Lombardi G; Smith CH; Ciccarelli FD; Barker JN; Capon F
J Invest Dermatol; 2020 Apr; 140(4):816-826.e3. PubMed ID: 31539532
[TBL] [Abstract][Full Text] [Related]
15. RNA sequencing-based longitudinal transcriptomic profiling gives novel insights into the disease mechanism of generalized pustular psoriasis.
Wang L; Yu X; Wu C; Zhu T; Wang W; Zheng X; Jin H
BMC Med Genomics; 2018 Jun; 11(1):52. PubMed ID: 29871627
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiology of generalized pustular psoriasis.
Iizuka H; Takahashi H; Ishida-Yamamoto A
Arch Dermatol Res; 2003 Apr; 295 Suppl 1():S55-9. PubMed ID: 12677433
[TBL] [Abstract][Full Text] [Related]
18. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
19. Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.
Krueger J; Puig L; Thaçi D
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):51-64. PubMed ID: 35061230
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
